eli lilly weight loss drug retatrutide Medscape | Retatrutide, Lilly's first-in-class triple hormone receptor agonist, delivered meaningful at 80 weeks in all doses in the VisualAbstract: Retatrutide reduces body weight

Zhu H, et al

Additionally, in a post-hoc analysis of the SURPASS-4 trials, tirzepatide showed a slower rate of eGFR decline and lower urinary albumin creatinine values as compared to patients who were treated with glargine insulin [75, 76]

And there is no clear path forward for GLP-1 coverage in Medicare after 2027 if the Medicare GLP-1 Bridge is not extended further and the BALANCE Model is not implemented

Why Clean Eatz Kitchen Works for GLP-1 Users Clean Eatz Kitchen offers a dedicated GLP-1 Meal Plan macro-balanced meals developed with registered dietitian input specifically for users on semaglutide and tirzepatide medications